Active Ingredient: ESKETAMINE HYDROCHLORIDE
Proprietary Name: SPRAVATO
Dosage Form; Route of Administration: SPRAY; NASAL
Strength: EQ 28MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N211243
Product Number: 001
Approval Date: Mar 5, 2019
Applicant Holder Full Name: JANSSEN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
